Properties
Description
JAK/HDAC-IN-1 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets HDAC, HDAC2, HDAC6, HDAC8, JAK1, JAK2, JAK3, and Tyk2.
Molecular Formula
C19H21Cl2N7O2
Targets
HDAC: 2 nM; HDAC2: 14 nM; HDAC6: 120 nM; HDAC8: 2470 nM; JAK1: 4.8 nM; JAK2: 4 nM; JAK3: 7.4 nM; Tyk2: 49 nM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
JAK/HDAC-IN-1 is researched for its dual inhibition of JAK kinases and HDACs, particularly in hematological malignancies.